SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 305 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55,621,191 | -4.6% | 458,845 | -9.8% | 0.10% | -2.9% |
| Q2 2023 | $58,272,929 | -40.7% | 508,845 | -28.6% | 0.10% | -52.8% |
| Q1 2023 | $98,249,910 | +12.6% | 712,834 | +5.8% | 0.22% | -35.9% |
| Q4 2022 | $87,286,643 | -35.9% | 673,612 | -45.3% | 0.34% | -23.4% |
| Q3 2022 | $136,119,000 | +57.0% | 1,231,396 | +6.5% | 0.44% | +88.8% |
| Q2 2022 | $86,684,000 | -5.6% | 1,156,396 | -1.6% | 0.23% | +26.6% |
| Q1 2022 | $91,853,000 | -6.8% | 1,175,796 | +7.4% | 0.18% | +0.5% |
| Q4 2021 | $98,605,000 | +1098.1% | 1,095,000 | +1130.3% | 0.18% | +1207.1% |
| Q3 2021 | $8,230,000 | +218.9% | 89,000 | +345.0% | 0.01% | +40.0% |
| Q4 2019 | $2,581,000 | – | 20,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |